News
CASIF
0.243
+17.06%
0.035
*News On CASI Pharmaceuticals Inc. (CASI) Now Under CASIF
Dow Jones · 10h ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara
Reuters · 1d ago
Nasdaq Gains Over 1%; TJX Posts Upbeat Earnings
Benzinga · 1d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
Reuters · 1d ago
CASI Pharmaceuticals to Be Delisted From Nasdaq, Shares Expected to Move to OTC Market
TipRanks · 1d ago
Dow Jumps 200 Points; Lowe's Issues Weak Earnings Outlook
Benzinga · 1d ago
Casi Pharmaceuticals receives delisting decision from Nasdaq
TipRanks · 1d ago
CASI Pharmaceuticals to be delisted from Nasdaq, shares to move to OTC Market
Seeking Alpha · 1d ago
CASI Pharmaceuticals To Be Delisted From Nasdaq, Effective Feb. 26
Benzinga · 1d ago
Nasdaq Panel Orders CASI Pharmaceuticals Delisting, Trading Halt Set for Feb. 26
Reuters · 1d ago
Weekly Report: what happened at CASI last week (0216-0220)?
Weekly Report · 3d ago
CASI Pharmaceuticals Closes Third Tranche of US$20 Million Convertible Note Financing
TipRanks · 6d ago
CASI Pharmaceuticals Names New Executive Chairman, Streamlines U.S. Operations Amid Listing Pressure
TipRanks · 02/19 15:01
CASI PHARMACEUTICALS - TO TAKE CERTAIN APPROPRIATE MEASURES TO FURTHER STREAMLINE CO'S BRANCHES, PERSONNEL, RELATED ACTIVITIES IN THE U.S.
Reuters · 02/19 14:04
CASI Pharmaceuticals Names Dr. Wei-Wu He Executive Chairman as James Huang Steps Down
Reuters · 02/19 14:01
Weekly Report: what happened at CASI last week (0209-0213)?
Weekly Report · 02/16 10:31
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 02/13 17:05
BRIEF-Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
Reuters · 02/10 15:17
More
Webull provides a variety of real-time CASIF stock news. You can receive the latest news about Casi Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About CASIF
CASI Pharmaceuticals Inc is a holding company principally engaged in developing and commercializing innovative therapeutics and pharmaceutical products. The Company’s main business is engaged in acquiring, developing and commercializing products that augment its hematology oncology, autoimmune and organ transplant rejection therapeutic area focus as well as other unmet medical need. The Company’s main products include EVOMELA (Melphalan for Injection), FOLOTYN (Pralatrexate), CNCT19, BI-1206, CB-5339, CID-103, Thiotepa and others. The Company mainly conducts its business in the domestic market.